The experts group stats & facts
Experts
Countries
Publications
Recent updates
A Markov-model simulation of IVF programs for PCOS patients indicates that coupling myo-Inositol with rFSH is cost-effective for the Italian Health System
Authors: Beresniak A, Russo M, Forte G, Laganà AS, Oliva MM, Aragona C, Chiantera V, Unfer V.
Myo-inositol in assisted reproductive technology from bench to bedside
Authors: Andrea Etrusco, Antonio Simone Laganà, Vito Chiantera, Giovanni Buzzaccarini, and Vittorio Unfer
Questioning PCOS phenotypes for reclassification and tailored therapy
Authors: Harry Myers S., Russo M., Dinicola S., Forte G., Unfer V.
Diet Plus Inositols, α-Lactalbumin and Gymnema sylvestre: The Successful Combo to Restore Body Weight and Metabolic Profile in Obese and Dysmetabolic Patients
Authors: Basciani S, Nordio M, Dinicola S, Unfer V and Gnessi L.

EGOI ATTENDS ESHRE 2023
Authors: EGOI Members
Treatment with Myo-Inositol Does Not Improve the Clinical Features in All PCOS Phenotypes
Authors: Porcaro, G.; Bilotta, G.; Capoccia, E.; Bezerra Espinola, M.S.; Aragona, C.
D-Chiro-Inositol in Endometrial Hyperplasia: A Pilot Study
Authors: Porcaro, G.; Bilotta, G.; Capoccia, E.; Bezerra Espinola, M.S.; Aragona, C.
Comparing the Efficacy of Myo-Inositol Plus -Lactalbumin vs. Myo-Inositol Alone on Reproductive and Metabolic Disturbances of Polycystic Ovary Syndrome
Authors: Zdravko Kamenov, Antoaneta Gateva, Simona Dinicola, and Vittorio Unfer

the EGOI International School of Rome
Authors: EGOI Members

DIP 2023 Symposium: EGOI joins in
Authors: EGOI Members